Loading clinical trials...
Loading clinical trials...
The Effect of a PPAR Alpha Agonist on CYP Monooxygenase Activity in Humans
Conditions
Interventions
fenofibrate
Placebo
Locations
1
United States
Vanderbilt University
Nashville, Tennessee, United States
Start Date
September 1, 2009
Primary Completion Date
January 1, 2012
Completion Date
January 1, 2012
Last Updated
June 28, 2013
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Vanderbilt University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions